
Keywords: موانا; Influenza; Virus; Neuraminidase; Inhibitor; Pharmacokinetics; Molecular modeling; BQLKEXSYWRBWQK-AFMQGRBTSA-N; AUC; area under the concentration-versus-time curve; CC50; 50% cytotoxicity concentration; CL; clearance; CPE; cytopathic effect; D; distributio